Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Paul Guedeney, Bimmer E. Claessen, Usman Baber, Anton Camaj, Sabato Sorrentino, Melissa Aquino, Moritz Blum, Rishi Chandiramani, Ridhima Goel, Sherif Elsayed, Jason C. Kovacic, Joseph Sweeny, Nitin Barman, Pedro Moreno, George D. Dangas, Annapoorna Kini, Samin Sharma, Roxana Mehran

Research output: Contribution to JournalArticleAcademicpeer-review

6 Citations (Scopus)


Intensive low-density lipoprotein cholesterol (LDL-C)reduction with statins is recommended after elective percutaneous coronary intervention (PCI). We aimed to evaluate adherence to guideline-recommended statin therapy (GRST)and the rate of residual cholesterol risk (RCR)at follow-up after elective PCI. All patients who underwent elective PCI between January 2010 and May 2016 were prospectively included in this single-center study. GRST was defined as high-intensity statin (HIS)therapy for patients ≤75 years old and moderate-intensity statin (MIS)or HIS therapy for patients >75 years. RCR at follow-up was defined as <50% decrease in LDL-C with HIS or <30% with MIS for statin-naïve patients and as LDL-C >70 mg/dL for nonstatin-naïve patients. A total of 2,653 patients were included, with 1,304 (49.2%)discharged with GRST. There was a significant increase in the number of patients discharged with GRST over time from 44.2% in 2010 to 63.0% in 2016 (p <0.001). Conversely, RCR at follow-up was present in 1,120 patients (42.2%)overall and remained stable over time. Risk factors of RCR at follow-up were female gender (odds ratio [OR]: 1.38; 95% confidence interval [CI]1.13 to 1.70), previous myocardial infarction (OR: 1.37; 95% CI 1.12 to 1.64), smoking (OR: 1.30; 95% CI 1.01 to 1.67), higher LDL-C level at baseline (OR: 1.22; 95% CI 1.18 to 1.25). The presence of RCR was associated with an increased adjusted risk of death within 1 year of the second LDL-C measurement (adjHR: 2.78; 95% CI 1.15 to 6.67). In conclusion, although the rate of GRST at discharge has improved significantly over time in patients who underwent elective PCI, the prevalence of RCR at follow-up has not changed appreciably suggesting that further implementation of guidelines as well as novel or more intensive pharmacotherapy may be warranted.

Original languageEnglish
Pages (from-to)1788-1795
Number of pages8
JournalAmerican journal of cardiology
Issue number11
Publication statusPublished - 1 Jun 2019

Cite this